Table 2 Patient characteristics and hypoglycemic treatment
From: Meeting individualized glycemic targets in primary care patients with type 2 diabetes in Spain
Sex (% men) | 53 | |
Age (years) | 66.7 ± 10.8 | |
BMI (kg/m2) | 29.9 ± 5 | |
Duration of diabetes (years) | 8.8 ± 6.3 | |
HbA1c (%/mmol/mol) | 7.3 ± 1.2/56 ± 9.2 | |
Diabetes complications (%) | 43.6 | |
Macrovascular | 23 | |
Microvascular | 23.5 | |
Hypoglycemic treatment (%) | Oral agents (OA) only | 77.7 |
•Sulphonylureas or glinides | 26.7 | |
Insulin with/without OA | 22.3 | |
•≥2 doses | 9.3 | |
Previous hypoglycemia that required medical assistance during the last year (%) | 6.8 | |